DrugDashboards

Apretude

Cabotegravir · Kit · ViiV Healthcare Company

NDC 49702-0280-63 · 1 KIT in 1 CARTON * 3 mL in 1 VIAL · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicaid spend (2026 YTD · Q1)

$44
12 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $3,818.86 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA215499
TE code
Approval date
Dec 20, 2021
Patents / exclusivity
4 patents, 1 exclusivities
TypeNumber / codeExpires
exclusivityNCEJan 21, 2026
patent12138264Sep 15, 2031
patent11224597Sep 15, 2031
patent8410103Feb 4, 2031
patent10927129Apr 28, 2026

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Cabotegravir (Kit)

LabelerStrengthFirst seenLast seen
ViiV Healthcare CompanyJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Apretude — NDC 49702-0280-63," retrieved September 3, 2026, https://drugdashboards.com/drug/49702028063.

Free to cite with attribution — see how the data is put together.